Press Releases

Trinity Biotech Announces Q4 and FY’16 Financial Results

March 14, 2017

Trinity Biotech Announces Q4 2016 Financial Results

Trinity Biotech to Announce Q4 and FY 2016 Results

February 24, 2017

Trinity Biotech to Announce Q4 and FY 2016 Results

Trinity Biotech Announces Q3 ’16 Financial Results

October 25, 2016

Trinity Biotech Announces Q3 2016 Financial Results

Trinity Biotech to Announce Q3 2016 Financial Results

October 12, 2016

trinity-biotech-to-announce-q3-2016-results

Trinity Biotech Announces Withdrawal of Troponin FDA 510(k) Submission

October 4, 2016

trinity-biotech-announces-withdrawal-of-troponin-fda-510k-submission

Trinity Biotech Announces Q2 2016 Financial Results

July 21, 2016

trinity-biotech-announces-q2-2016-results

Trinity Biotech to Announce Q2 2016 Financial Results

July 14, 2016

Trinity Biotech to Announce Q2 2016 Results

Trinity Biotech Announces Q1 2016 Financial Results

April 19, 2016

Trinity Biotech Announces Q1 2016 Financial Results

Trinity Biotech to Announce Q1 2016 Financial Results

April 15, 2016

Trinity Biotech to Announce Q1 2016 Financial Results

Trinity Biotech Announces Q4 and FY 15 Financial Results

March 3, 2016

Trinity Biotech Announces Q4 2015 Financial Results

Trinity Biotech to Announce Q4 and FY2015 Financial Results

February 26, 2016

Trinity Biotech to Announce Q4 2015 Financial Results

Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product

December 17, 2015

Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product

Trinity Biotech Announces Q3 2015 Financial Results

October 23, 2015

Trinity Biotech Announces Q3 2015 Financial Results

Download

Trinity Biotech to Announce Q3 2015 Financial Results

October 13, 2015 Download

Trinity Biotech Announces Q2 2015 Financial Results

July 28, 2015 Download

Trinity Biotech to Announce Q2 2015 Financial Results

July 17, 2015 Download

Trinity Biotech Announces Q1 2015 Financial Results

April 30, 2015 Download

Trinity Biotech to Announce Q1 2015 Financial Results

April 23, 2015 Download

Trinity Biotech Closes Offering of $115m of 4pc Exchangeable Senior Notes due 2045

April 9, 2015 Download

Trinity Biotech plc Prices Offering of $100 Million of 4.00% Exchangeable Senior Notes due 2045

April 2, 2015 Download